Pallas Capital Advisors’s Boston Scientific BSX Stock Holding History

Pallas Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$540K	Buy	8,610 +5,291	+159%	+$423K	0.02%	488
2025 Q4	$316K	Sell	3,319 -3,565	-52%	-$350K	0.01%	664
2025 Q3	$672K	Buy	6,884 +721	+12%	+$74.7K	0.02%	439
2025 Q2	$662K	Buy	6,163 +2,132	+53%	+$216K	0.03%	423
2025 Q1	$407K	Sell	4,031 -42	-1%	-$4.23K	0.02%	528
2024 Q4	$364K	Sell	4,073 -343	-8%	-$30.2K	0.02%	440
2024 Q3	$376K	Buy	4,416 +10	+0.2%	+$788	0.02%	414
2024 Q2	$333K	Sell	4,406 -523	-11%	-$38.3K	0.02%	389
2024 Q1	$338K	Buy	4,929 +878	+22%	+$56.5K	0.01%	343
2023 Q4	$234K	Buy	+4,051	New	+$216K	0.01%	340

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pallas Capital Advisors's BSX Position: Q1 2026 in Review

Pallas Capital Advisors increased its Boston Scientific (BSX) stake by 159% in Q1 2026, buying an estimated $423K and bringing the position to 8,610 shares worth $540K. The position accounts for 0.02% of the portfolio, ranked #488.

Pallas Capital Advisors first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $672K in Q3 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Pallas Capital Advisors held 8,610 shares of Boston Scientific worth $540K as of Q1 2026.
Pallas Capital Advisors bought 5,291 Boston Scientific shares in Q1 2026, an estimated $423K.
Boston Scientific made up 0.02% of Pallas Capital Advisors's portfolio in Q1 2026, its #488 holding.
Pallas Capital Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
Pallas Capital Advisors's Boston Scientific position peaked at $672K in Q3 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.